• Publications
  • Influence
Homocysteine and reclassification of cardiovascular disease risk.
Traditional cardiovascular risk factors and severity of angiographic coronary artery disease in the elderly.
Over 80% of annual coronary heart disease mortality occurs in the elderly, a rapidly expanding subset of the population. The authors retrospectively examined the relationship between traditional
Prognostic Value of Coronary Flow Reserve in Patients with Dialysis-Dependent ESRD.
TLDR
Global CFR may provide independent and incremental risk stratification for all-cause and cardiovascular mortality in patients with dialysis-dependent ESRD, and addition of global CFR resulted in risk reclassified in 27% of patients.
A gender-stratified comparative analysis of various definitions of metabolic syndrome and cardiovascular risk in a multiethnic U.S. population.
TLDR
The newly defined consensus criteria for metabolic syndrome was found to be similarly predictive of cardiovascular events when compared to existing definitions and significant gender differences exist in the association between metabolic syndrome, its individual components, and CVD.
Induction of the CXC Chemokine Interferon-&ggr;–Inducible Protein 10 Regulates the Reparative Response Following Myocardial Infarction
TLDR
Endogenous IP-10 is an essential inhibitory signal that regulates the cellular composition of the healing infarct and promotes wound contraction, attenuating adverse remodeling in fibroblast-populated collagen lattices.
Ranolazine in Symptomatic Diabetic Patients Without Obstructive Coronary Artery Disease: Impact on Microvascular and Diastolic Function
TLDR
In symptomatic diabetic patients without obstructive coronary artery disease, ranolazine did not change exercise‐stimulated myocardial blood flow or CFR but did modestly improve diastolic function.
Association of cystatin C with measures of obesity and its impact on cardiovascular events among healthy US adults.
TLDR
CysC correlated better with measures of visceral adiposity compared to BMI and appears to be a better predictor of adverse cardiovascular outcomes among those with anthropometric measures not suggestive of obesity compared to those with abnormal measures of anthropometry.
...
...